Column Group LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $160 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tenaya Therapeutics, Inc. with a value of $49.2M, Oric Pharmaceuticals, Inc. with a value of $48.7M, Ngm Biopharmaceuticals Inc with a value of $28.8M, Rapt Therapeutics, Inc. with a value of $24.1M, and Surrozen, Inc. with a value of $9.69M.

Examining the 13F form we can see an increase of $9.05M in the current position value, from $151M to 160M.

Column Group LLC is based out at San Francisco, CA

Below you can find more details about Column Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $160 Million
Healthcare: $160 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 7
  • Current Value $160 Million
  • Prior Value $151 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Column Group LLC Portfolio

Follow Column Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.